Shares of The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 958.04 ($12.09) and traded as low as GBX 850.45 ($10.73). The Biotech Growth Trust shares last traded at GBX 852 ($10.75), with a volume of 48,347 shares traded.
The Biotech Growth Trust Trading Down 1.1 %
The company has a current ratio of 0.59, a quick ratio of 0.00 and a debt-to-equity ratio of 11.02. The company has a market cap of £239.41 million, a price-to-earnings ratio of 2.81 and a beta of 0.50. The firm's 50-day moving average price is GBX 867.04 and its 200 day moving average price is GBX 955.78.
The Biotech Growth Trust (LON:BIOG - Get Free Report) last posted its quarterly earnings results on Wednesday, November 27th. The company reported GBX 0.20 ($0.00) EPS for the quarter. The Biotech Growth Trust had a net margin of 95.33% and a return on equity of 26.96%.
Insider Activity
In other The Biotech Growth Trust news, insider Julie Tankard acquired 1,022 shares of The Biotech Growth Trust stock in a transaction dated Wednesday, December 4th. The stock was purchased at an average cost of GBX 972 ($12.26) per share, for a total transaction of £9,933.84 ($12,533.23). Also, insider Hamish Baillie purchased 3,000 shares of the business's stock in a transaction on Wednesday, November 27th. The shares were bought at an average price of GBX 931 ($11.75) per share, with a total value of £27,930 ($35,238.46). Insiders bought a total of 6,222 shares of company stock worth $5,659,584 in the last three months. Company insiders own 0.71% of the company's stock.
About The Biotech Growth Trust
(
Get Free Report)
The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).
Featured Articles
Before you consider The Biotech Growth Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.
While The Biotech Growth Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
